Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Perry

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.
American Journal of Clinical Oncology|April 1, 1993
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group BS D Luikart, M Goutsou, E D Mitchell, et al.
American Journal of Clinical Oncology|February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)S D Luikart, J E Herndon, D R Hollis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group BT A Ahles, P M Silberfarb, J Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B studyL H Maurer, J E Herndon, D R Hollis, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Induction treatment for resectable non-small-cell lung cancerM C Perry, J Deslauriers, K S Albain, et al.
Cancer|February 17, 2001
Social support as a buffer to the psychological impact of stressful life events in women with breast cancerA B Kornblith, J E Herndon, E Zuckerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140H L Parnes, C Cirrincione, J Aisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicityM A Socinski, C Zhang, J E Herndon, et al.
American Journal of Clinical Oncology|April 1, 1993
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group BS D Luikart, M Goutsou, E D Mitchell, et al.
American Journal of Clinical Oncology|February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)S D Luikart, J E Herndon, D R Hollis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group BT A Ahles, P M Silberfarb, J Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B studyL H Maurer, J E Herndon, D R Hollis, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Induction treatment for resectable non-small-cell lung cancerM C Perry, J Deslauriers, K S Albain, et al.
Cancer|February 17, 2001
Social support as a buffer to the psychological impact of stressful life events in women with breast cancerA B Kornblith, J E Herndon, E Zuckerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140H L Parnes, C Cirrincione, J Aisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B studyM Perloff, L Norton, A H Korzun, et al.
Pageof 16